Navigation Links
Monitor in Medical Technology

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... hepatic impairment. ECGs should be obtained to monitor the QTc at baseline, seven days after ... or hypomagnesemia prior to administration and monitor periodically. Avoid drugs known to prolong the QT ... abnormalities prior to initiating Tasigna and monitor periodically during therapy. Hepatic ...

GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP

... with moderate to severe hepatic disease and monitor closely. Bone Marrow Reticulin Formation ... Monitoring: Complete Blood Counts (CBCs) -- monitor CBCs, including platelet counts and WBC ... 3 to 5 days. If the abnormalities are confirmed, monitor serum liver tests weekly until the ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... hepatic impairment. ECGs should be obtained to monitor the QTc at baseline, seven days after initiation, ... or hypomagnesemia prior to administration and monitor periodically. Avoid drugs known to prolong the QT ... abnormalities prior to initiating Tasigna and monitor periodically during therapy. Hepatic ...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

... with moderate to severe hepatic disease and monitor closely. Bone Marrow Reticulin ... Monitoring: Complete Blood Counts (CBCs) - monitor CBCs, including platelet counts and WBC ... discontinuation of PROMACTA. Liver tests: monitor serum liver tests (ALT, AST, total and ...

Aon eSolutions Launches Clinical Trials Module

... RiskConsole, risk managers have the ability to monitor clinical trials worldwide, so they have ... -- Time-stamping enables risk managers to monitor and determine the current stage and ongoing ... capabilities accommodate the need to monitor clinical trial exposure worldwide. -- Automatic ...

DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes

... Indicate GlycoMark May Be a More Effective monitor Than Hemoglobin A1C of Exenatide, Sitagliptin, ... role of the GlycoMark test to effectively monitor patients with diabetes," said Eric Button, ... (see below) evaluating the use of GlycoMark to monitor exenatide, pramlintide, sitagliptin, and biphasic ...

Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting

... your doctor will routinely do blood tests to monitor your kidney function. If you have kidney ... hepatic impairment. ECGs should be obtained to monitor the QTc at baseline, seven days after initiation, ... hypomagnesemia prior to administration and monitor periodically. Avoid drugs known to prolong the QT ...

Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home

... and supplies for all long-term warfarin users who monitor their prothrombin time at home with a ... doctor's office or a centralized location can monitor their INR at home. If they test more often, it's ... et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. ...

Microlife's Home Blood Pressure Monitors Proven Accurate Even for Critical Patients

... Manufactures the Only Home Blood Pressure monitor with Proven Accuracy (Severe ... patients are recognizing the need to accurately monitor blood pressure at home. A "true pressure" is ... patients should only measure at home with a monitor that can prove accuracy through independently ...

Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces

... that allow both local and remote operators to monitor and access multiple computers from multiple ... features independently retractable 17" LCD monitor and keyboard with built-in touchpad. To ... even with the server rack door closed -- to monitor and troubleshoot servers. The KL1116 features ...

CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment

... The authors stated that eNO is a valuable tool to manage ICS and monitor its effects. The American Thoracic Society is presently ... CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of ...

West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial

... be in the range of $10 Billion per year. With the newfound ability to monitor multiple highly relevant physiologic parameters on a continuous 24/7 basis ... of non-invasive wireless technology and sensors to transform the way we monitor cardiac patients on a continuous and remote basis," added Topol. ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... Your doctor will test you for TB before starting SIMPONI(TM) and will monitor you for signs of TB during treatment. Tell your doctor if you have been in ... worse in people who use TNF blockers like SIMPONI(TM). Your doctor will monitor you closely if you have heart failure. Tell your doctor right away if you ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... Your doctor will test you for TB before starting SIMPONI(TM) and will monitor you for signs of TB during treatment. Tell your doctor if you have been in ... worse in people who use TNF blockers like SIMPONI(TM). Your doctor will monitor you closely if you have heart failure. Tell your doctor right away if you ...

National Hemovigilance Pilot Program Launches to Track Adverse Events Associated with Blood Transfusion

... developed country that does not have an established method to track and monitor adverse events associated with blood transfusion on a national level," ... ever been, this country lacks a coordinated national network to track and monitor adverse events associated with the transfusion of blood and blood ...

Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)

... test; An 11.3% decrease in serum fructosamine, which is used to monitor short-term (2-3 weeks) blood sugar control; and A 0.4% decrease in hemoglobin A1C (HbA1C), used to monitor longer-term (2-3 months) blood sugar control. "It is ...

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

... not to exceed the upper safety limit of 12 g/dL. monitor hemoglobin regularly during therapy, weekly until hemoglobin becomes ... evaluated. Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to 20% ...

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting

... transfusion and not to exceed the upper safety limit of 12 g/dL. -- monitor hemoglobin regularly during therapy, weekly until hemoglobin becomes ... evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal ...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

... treatment of latent tuberculosis infection prior to therapy with CIMZIA. monitor patients receiving CIMZIA for signs and symptoms of active tuberculosis, ... Exercise caution when using CIMZIA in patients who have heart failure and monitor them carefully. Treatment with CIMZIA may result in the formation of ...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

... treatment of latent tuberculosis infection prior to therapy with CIMZIA. monitor patients receiving CIMZIA for signs and symptoms of active tuberculosis, ... Exercise caution when using CIMZIA in patients who have heart failure and monitor them carefully. Treatment with CIMZIA may result in the formation of ...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

... treatment of latent tuberculosis infection prior to therapy with CIMZIA. monitor patients receiving CIMZIA for signs and symptoms of active tuberculosis, ... Exercise caution when using CIMZIA in patients who have heart failure and monitor them carefully. Treatment with CIMZIA may result in the formation of ...

Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center

... cancer. Additionally, a medical surveillance program will be developed to monitor for any occurrence of breast or related cancers. That may include more ... by the team at Good Samaritan, and she will continue to carefully monitor her health and have regular exams to ensure she stays cancer-free. "The ...

Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital

... promote occupational health and safety while expanding the capacity to monitor immune systems. We applaud the Clinton Global Initiative for building ... Exposure Prevention Information Network (EPINet) surveillance system to monitor occupational injuries at BMMH. BD will also provide a range of safe ...

Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea

... Seng Memorial Hospital (in Busan) The ImmuKnow assay will be used to monitor all patients over a period of 36 months from initiation of treatment to ... Spain,* have demonstrated the potential of the ImmuKnow assay as a tool to monitor the immune status of patients following kidney transplantation. "The ...

New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation

... in Santander, Spain, used the Cylex ImmuKnow assay to prospectively monitor intracellular adenosine triphosphate (ATP) concentrations following CD4 ... elucidate the appropriate standards for use of cell-mediated immunity to monitor risk for infection and rejection in selected patient categories. However, ...

New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients

... and his colleagues focused on the use of the Cylex ImmuKnow assay to monitor cell-mediated immunity post-transplant in pediatric patients between 1 and ... that seek to resolve questions about the use of ImmuKnow as a tool to monitor pediatric transplant patients and their levels of cell ...

Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions

... level sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease

... of latent tuberculosis infection prior to therapy with Cimzia(R). monitor patients receiving Cimzia(R) for signs and symptoms of active ... caution when using Cimzia(R) in patients who have heart failure and monitor them carefully. Treatment with Cimzia(R) may result in the formation of ...

New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... level sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer

... Herbert Lepor, Chairman of Urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical trial program evaluating the safety and ...

Apieron, Inc. Begins Customer Shipments of the Insight(TM) eNO System

... All of the System's functions are accessible through a small desktop monitor with a large color display and clinician-friendly interface. "We ... Park, CA that was funded in 2003 to develop a simple-to-use, non- invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of ...

Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics

... than traditional methods to enable the cardiologists to better diagnose, monitor and track the efficacy of treatments," said Joseph Ashley, CEO of ... About VentriPoint Diagnostics VentriPoint creates diagnostic tools to monitor patients with heart disease -- the number one cause of death in developed ...

Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings

... level sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home

... training, equipment and supplies for all long-term warfarin users who monitor their own PT/INR results at home with portable meters, such as the ... SS, White RH, Hill J, et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a ...

Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote

... sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia

... sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents

... level sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting

... sufficient to avoid transfusion and not to exceed 12 g/dL. -- monitor hemoglobin regularly during therapy, more frequently following a ... contraception evaluated. -- Prior to and regularly during PROCRIT therapy monitor iron status; transferrin saturation should be greater than or equal to ...

New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

... experienced their first severe infusion reaction during later infusions. monitor patients for 1-hour following ERBITUX infusions in a setting with ... abnormalities occurred days to months after initiation of ERBITUX. monitor patients periodically for hypomagnesemia, hypocalcemia and hypokalemia, ...

Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award

... Development, Abbott Molecular. The RealTime HIV-1 assay is intended to monitor disease prognosis and for use as an aid in assessing viral response to ... diagnose disease and infections earlier, select appropriate therapies and monitor disease progression. In addition to the RealTime HIV-1 viral load test and ...
Other Contents
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/1/2015)... Greifensee, Switzerland (PRWEB) , ... September 01, 2015 ... ... “Calibration and Qualification of Laboratory Instruments in accordance with GMP requirements“ , ... be presented on October 6th, 2015 at 11:00 EDT (15:00 GMT). , ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Mercy Health (formerly ... devoted the 10th of its monthly Mercy Health: Helping You Be Well videos to ... in seven men. , In a concise video on Mercy Health’s YouTube channel, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... 9, 2015 from 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 ... with career opportunities will be attending from across the country. All specialties will ...
(Date:9/1/2015)... ... September 01, 2015 , ... Éminence Organic Skin Care ... VitaSkin™ Exfoliating Peels. This revolutionary collection of natural peel solutions complements the existing ... , Formulated with alpha hydroxy acids and natural active ingredients, these results-oriented ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It ... rapidly-growing alliance is dedicated to the provision of quality addiction treatment and ...
Breaking Medicine News(10 mins):Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:MAP Health Management Launches the MAP Recovery Network 2
Other TagsOther Tags